Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,716 | -2,286 | -1,150 | -4,631 | -3,115 |
| Depreciation Amortization | 21 | 20 | 14 | 58 | 44 |
| Accounts payable and accrued liabilities | 12 | -37 | 155 | 159 | 46 |
| Other Working Capital | -916 | 54 | -228 | 763 | 154 |
| Other Operating Activity | 392 | 213 | 15 | 1,137 | 946 |
| Operating Cash Flow | $-4,207 | $-2,036 | $-1,194 | $-2,514 | $-1,925 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 360 | 360 | 100 | -18 | -18 |
| Investing Cash Flow | $360 | $360 | $100 | $-18 | $-18 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,840 | 3,849 | 3,613 | 5,866 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -60 | -60 |
| Financing Cash Flow | $4,840 | $3,849 | $3,613 | $5,806 | $-60 |
| Beginning Cash Position | 23,081 | 23,081 | 23,081 | 19,807 | 19,807 |
| End Cash Position | 24,074 | 25,254 | 25,600 | 23,081 | 17,804 |
| Net Cash Flow | $993 | $2,173 | $2,519 | $3,274 | $-2,003 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,207 | -2,036 | -1,194 | -2,514 | -1,925 |
| Capital Expenditure | N/A | N/A | N/A | -18 | -18 |
| Free Cash Flow | -4,207 | -2,036 | -1,194 | -2,532 | -1,943 |